According to a new research report Alzheimer’s Disease Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” published by P&S Market Research, Alzheimer’s disease currently exhibits a pipeline with 89 active drug candidates.

Access Report Overview: https://www.psmarketresearch.com/market-analysis/alzheimers-disease-pipeline-analysis

Alzheimer’s disease pipeline offers novel therapeutic targets for the treatment of Alzheimer’s disease.

Download Free Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/alzheimers-disease-pipeline-analysis/report-sample


The study analyzed that the Alzheimer’s disease pipeline comprises 89 drug candidates in different stages of development.


Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=alzheimers-disease-pipeline-analysis

Some of the key players developing drugs for Alzheimer’s disease are Eli Lilly and Company, Genentech, Inc., Eisai Co., Ltd., and others.

Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com